• レポートコード:QYR2104Z4277 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、98ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥553,800 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥830,700 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、眼科治療のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(ジェル、眼科用液剤、カプセル&錠剤、点眼薬、軟膏)、用途別市場規模(病院、ドラッグストア)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・眼科治療の市場動向 ・企業の競争状況、市場シェア ・眼科治療の種類別市場規模(ジェル、眼科用液剤、カプセル&錠剤、点眼薬、軟膏) ・眼科治療の用途別市場規模(病院、ドラッグストア) ・眼科治療の北米市場規模2016-2027(アメリカ、カナダ) ・眼科治療のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・眼科治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・眼科治療の中南米市場規模2016-2027(メキシコ、ブラジル) ・眼科治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Allergan、Aerie Pharmaceuticals、Pfizer、Valeant、Bayer、Genentech、Novartis、Regeneron、Takeda、Santen Pharmaceutical) ・結論 |
Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others.
Market Analysis and Insights: Global Ophthalmology Treatment Market
The global Ophthalmology Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ophthalmology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ophthalmology Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ophthalmology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ophthalmology Treatment market.
Global Ophthalmology Treatment Scope and Market Size
Ophthalmology Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market by Application
1.3.1 Global Ophthalmology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmology Treatment Market Perspective (2016-2027)
2.2 Ophthalmology Treatment Growth Trends by Regions
2.2.1 Ophthalmology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ophthalmology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Ophthalmology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Ophthalmology Treatment Industry Dynamic
2.3.1 Ophthalmology Treatment Market Trends
2.3.2 Ophthalmology Treatment Market Drivers
2.3.3 Ophthalmology Treatment Market Challenges
2.3.4 Ophthalmology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmology Treatment Players by Revenue
3.1.1 Global Top Ophthalmology Treatment Players by Revenue (2016-2021)
3.1.2 Global Ophthalmology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Ophthalmology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ophthalmology Treatment Revenue
3.4 Global Ophthalmology Treatment Market Concentration Ratio
3.4.1 Global Ophthalmology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmology Treatment Revenue in 2020
3.5 Ophthalmology Treatment Key Players Head office and Area Served
3.6 Key Players Ophthalmology Treatment Product Solution and Service
3.7 Date of Enter into Ophthalmology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmology Treatment Breakdown Data by Type
4.1 Global Ophthalmology Treatment Historic Market Size by Type (2016-2021)
4.2 Global Ophthalmology Treatment Forecasted Market Size by Type (2022-2027)
5 Ophthalmology Treatment Breakdown Data by Application
5.1 Global Ophthalmology Treatment Historic Market Size by Application (2016-2021)
5.2 Global Ophthalmology Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ophthalmology Treatment Market Size (2016-2027)
6.2 North America Ophthalmology Treatment Market Size by Type
6.2.1 North America Ophthalmology Treatment Market Size by Type (2016-2021)
6.2.2 North America Ophthalmology Treatment Market Size by Type (2022-2027)
6.2.3 North America Ophthalmology Treatment Market Size by Type (2016-2027)
6.3 North America Ophthalmology Treatment Market Size by Application
6.3.1 North America Ophthalmology Treatment Market Size by Application (2016-2021)
6.3.2 North America Ophthalmology Treatment Market Size by Application (2022-2027)
6.3.3 North America Ophthalmology Treatment Market Size by Application (2016-2027)
6.4 North America Ophthalmology Treatment Market Size by Country
6.4.1 North America Ophthalmology Treatment Market Size by Country (2016-2021)
6.4.2 North America Ophthalmology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ophthalmology Treatment Market Size (2016-2027)
7.2 Europe Ophthalmology Treatment Market Size by Type
7.2.1 Europe Ophthalmology Treatment Market Size by Type (2016-2021)
7.2.2 Europe Ophthalmology Treatment Market Size by Type (2022-2027)
7.2.3 Europe Ophthalmology Treatment Market Size by Type (2016-2027)
7.3 Europe Ophthalmology Treatment Market Size by Application
7.3.1 Europe Ophthalmology Treatment Market Size by Application (2016-2021)
7.3.2 Europe Ophthalmology Treatment Market Size by Application (2022-2027)
7.3.3 Europe Ophthalmology Treatment Market Size by Application (2016-2027)
7.4 Europe Ophthalmology Treatment Market Size by Country
7.4.1 Europe Ophthalmology Treatment Market Size by Country (2016-2021)
7.4.2 Europe Ophthalmology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmology Treatment Market Size (2016-2027)
8.2 Asia-Pacific Ophthalmology Treatment Market Size by Type
8.2.1 Asia-Pacific Ophthalmology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ophthalmology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ophthalmology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Ophthalmology Treatment Market Size by Application
8.3.1 Asia-Pacific Ophthalmology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ophthalmology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ophthalmology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Ophthalmology Treatment Market Size by Region
8.4.1 Asia-Pacific Ophthalmology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ophthalmology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ophthalmology Treatment Market Size (2016-2027)
9.2 Latin America Ophthalmology Treatment Market Size by Type
9.2.1 Latin America Ophthalmology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Ophthalmology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Ophthalmology Treatment Market Size by Type (2016-2027)
9.3 Latin America Ophthalmology Treatment Market Size by Application
9.3.1 Latin America Ophthalmology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Ophthalmology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Ophthalmology Treatment Market Size by Application (2016-2027)
9.4 Latin America Ophthalmology Treatment Market Size by Country
9.4.1 Latin America Ophthalmology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Ophthalmology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmology Treatment Market Size (2016-2027)
10.2 Middle East & Africa Ophthalmology Treatment Market Size by Type
10.2.1 Middle East & Africa Ophthalmology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ophthalmology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ophthalmology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Ophthalmology Treatment Market Size by Application
10.3.1 Middle East & Africa Ophthalmology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ophthalmology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ophthalmology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Ophthalmology Treatment Market Size by Country
10.4.1 Middle East & Africa Ophthalmology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ophthalmology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Ophthalmology Treatment Introduction
11.1.4 Allergan Revenue in Ophthalmology Treatment Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Aerie Pharmaceuticals
11.2.1 Aerie Pharmaceuticals Company Details
11.2.2 Aerie Pharmaceuticals Business Overview
11.2.3 Aerie Pharmaceuticals Ophthalmology Treatment Introduction
11.2.4 Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2016-2021)
11.2.5 Aerie Pharmaceuticals Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Ophthalmology Treatment Introduction
11.3.4 Pfizer Revenue in Ophthalmology Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Valeant
11.4.1 Valeant Company Details
11.4.2 Valeant Business Overview
11.4.3 Valeant Ophthalmology Treatment Introduction
11.4.4 Valeant Revenue in Ophthalmology Treatment Business (2016-2021)
11.4.5 Valeant Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Ophthalmology Treatment Introduction
11.5.4 Bayer Revenue in Ophthalmology Treatment Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Genentech Business Overview
11.6.3 Genentech Ophthalmology Treatment Introduction
11.6.4 Genentech Revenue in Ophthalmology Treatment Business (2016-2021)
11.6.5 Genentech Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Ophthalmology Treatment Introduction
11.7.4 Novartis Revenue in Ophthalmology Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Regeneron
11.8.1 Regeneron Company Details
11.8.2 Regeneron Business Overview
11.8.3 Regeneron Ophthalmology Treatment Introduction
11.8.4 Regeneron Revenue in Ophthalmology Treatment Business (2016-2021)
11.8.5 Regeneron Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Ophthalmology Treatment Introduction
11.9.4 Takeda Revenue in Ophthalmology Treatment Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Santen Pharmaceutical
11.10.1 Santen Pharmaceutical Company Details
11.10.2 Santen Pharmaceutical Business Overview
11.10.3 Santen Pharmaceutical Ophthalmology Treatment Introduction
11.10.4 Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2016-2021)
11.10.5 Santen Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ophthalmology Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gels
Table 3. Key Players of Eye Solutions
Table 4. Key Players of Capsules & Tablets
Table 5. Key Players of Eye Drops
Table 6. Key Players of Ointments
Table 7. Global Ophthalmology Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ophthalmology Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Ophthalmology Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Ophthalmology Treatment Market Share by Regions (2016-2021)
Table 11. Global Ophthalmology Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Ophthalmology Treatment Market Share by Regions (2022-2027)
Table 13. Ophthalmology Treatment Market Trends
Table 14. Ophthalmology Treatment Market Drivers
Table 15. Ophthalmology Treatment Market Challenges
Table 16. Ophthalmology Treatment Market Restraints
Table 17. Global Ophthalmology Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Ophthalmology Treatment Market Share by Players (2016-2021)
Table 19. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmology Treatment as of 2020)
Table 20. Ranking of Global Top Ophthalmology Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Ophthalmology Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ophthalmology Treatment Product Solution and Service
Table 24. Date of Enter into Ophthalmology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ophthalmology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Ophthalmology Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Ophthalmology Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Ophthalmology Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Ophthalmology Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Ophthalmology Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Ophthalmology Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Ophthalmology Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Ophthalmology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Ophthalmology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Ophthalmology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Ophthalmology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Ophthalmology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Ophthalmology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Ophthalmology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Ophthalmology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Ophthalmology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Ophthalmology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Ophthalmology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Ophthalmology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ophthalmology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ophthalmology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ophthalmology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Ophthalmology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Ophthalmology Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Ophthalmology Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Ophthalmology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Ophthalmology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Ophthalmology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Ophthalmology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Ophthalmology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Ophthalmology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ophthalmology Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ophthalmology Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ophthalmology Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Ophthalmology Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Ophthalmology Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Ophthalmology Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan Company Details
Table 65. Allergan Business Overview
Table 66. Allergan Ophthalmology Treatment Product
Table 67. Allergan Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 68. Allergan Recent Development
Table 69. Aerie Pharmaceuticals Company Details
Table 70. Aerie Pharmaceuticals Business Overview
Table 71. Aerie Pharmaceuticals Ophthalmology Treatment Product
Table 72. Aerie Pharmaceuticals Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 73. Aerie Pharmaceuticals Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Ophthalmology Treatment Product
Table 77. Pfizer Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Valeant Company Details
Table 80. Valeant Business Overview
Table 81. Valeant Ophthalmology Treatment Product
Table 82. Valeant Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 83. Valeant Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Ophthalmology Treatment Product
Table 87. Bayer Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 88. Bayer Recent Development
Table 89. Genentech Company Details
Table 90. Genentech Business Overview
Table 91. Genentech Ophthalmology Treatment Product
Table 92. Genentech Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 93. Genentech Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Ophthalmology Treatment Product
Table 97. Novartis Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. Regeneron Company Details
Table 100. Regeneron Business Overview
Table 101. Regeneron Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 102. Regeneron Recent Development
Table 103. Takeda Company Details
Table 104. Takeda Business Overview
Table 105. Takeda Ophthalmology Treatment Product
Table 106. Takeda Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 107. Takeda Recent Development
Table 108. Santen Pharmaceutical Company Details
Table 109. Santen Pharmaceutical Business Overview
Table 110. Santen Pharmaceutical Ophthalmology Treatment Product
Table 111. Santen Pharmaceutical Revenue in Ophthalmology Treatment Business (2016-2021) & (US$ Million)
Table 112. Santen Pharmaceutical Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmology Treatment Market Share by Type: 2020 VS 2027
Figure 2. Gels Features
Figure 3. Eye Solutions Features
Figure 4. Capsules & Tablets Features
Figure 5. Eye Drops Features
Figure 6. Ointments Features
Figure 7. Global Ophthalmology Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Ophthalmology Treatment Report Years Considered
Figure 11. Global Ophthalmology Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Ophthalmology Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ophthalmology Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Ophthalmology Treatment Market Share by Regions (2022-2027)
Figure 15. Global Ophthalmology Treatment Market Share by Players in 2020
Figure 16. Global Top Ophthalmology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmology Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Ophthalmology Treatment Revenue in 2020
Figure 18. Global Ophthalmology Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Ophthalmology Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Ophthalmology Treatment Market Share by Type (2016-2027)
Figure 22. North America Ophthalmology Treatment Market Share by Application (2016-2027)
Figure 23. North America Ophthalmology Treatment Market Share by Country (2016-2027)
Figure 24. United States Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ophthalmology Treatment Market Share by Type (2016-2027)
Figure 28. Europe Ophthalmology Treatment Market Share by Application (2016-2027)
Figure 29. Europe Ophthalmology Treatment Market Share by Country (2016-2027)
Figure 30. Germany Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ophthalmology Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Ophthalmology Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Ophthalmology Treatment Market Share by Region (2016-2027)
Figure 40. China Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ophthalmology Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Ophthalmology Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Ophthalmology Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ophthalmology Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Ophthalmology Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Ophthalmology Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Ophthalmology Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 60. Aerie Pharmaceuticals Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 62. Valeant Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 64. Genentech Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 66. Regeneron Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 67. Takeda Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 68. Santen Pharmaceutical Revenue Growth Rate in Ophthalmology Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed